Recently by Dr. David Brownstein: Don’t Let the FDA Get Away With It!
New data from the Framingham Heart Study finds that low LDL-cholesterol is related to the future development of cancer. Scientists studied 201 participants with cancer who were matched with 201 controls who were cancer free. The researchers looked at the trend of LDL-cholesterol for an extended period of time prior to cancer diagnosis, using data taken at four points over an average of 18.7 years prior to diagnosis. They found that LDL-cholesterol levels were lower in the participants with cancer than their matched controls at each of the data points.
As compared to the cancer-free subjects, the trend of low LDL-cholesterol in those who developed cancer was consistent throughout the period of the study. (Medicalnewstoday.com 3.27.2012)
This is another, in an ever-growing number of studies showing an association between low cholesterol (including LDL-cholesterol) and cancer development. The AMA and most cardiologists have been beating the drum claiming that we need to lower cholesterol levels down to numbers only obtainable through the use of medications such as statin drugs.
David Brownstein, M.D. is a Board-Certified family physician and is one of the foremost practitioners of holistic medicine. He is the Medical Director of the Center for Holistic Medicine in West Bloomfield, MI. Dr. Brownstein has lectured internationally to physicians and others about his success in using natural hormones and nutritional therapies in his practice.